Related Experiment Video
Updated: Nov 21, 2025
An Open Source Technology Platform to Manufacture Hydrogel-Based 3D Culture Models in an Automated and Standardized Fashion
Published on: March 31, 2022
Improving preclinical studies through replications
Natascha Ingrid Drude1,2, Lorena Martinez Gamboa1,2, Meggie Danziger1,2
1Department of Experimental Neurology, Charité-Universitätsmedizin, Berlin, Germany.
Abstract:
The purpose of preclinical research is to inform the development of novel diagnostics or therapeutics, and the results of experiments on animal models of disease often inform the decision to conduct studies in humans. However, a substantial number of clinical trials fail, even when preclinical studies have apparently demonstrated the efficacy of a given intervention. A number of large-scale replication studies are currently trying to identify the factors that influence the robustness of preclinical research. Here, we discuss replications in the context of preclinical research trajectories, and argue that increasing validity should be a priority when selecting experiments to replicate and when performing the replication. We conclude that systematically improving three domains of validity - internal, external and translational - will result in a more efficient allocation of resources, will be more ethical, and will ultimately increase the chances of successful translation.
Insights
Replication studies in preclinical research aim to improve the reliability of findings. Focusing on internal, external, and translational validity enhances research efficiency, ethics, and clinical trial success rates.
Area of Science:
- Biomedical Research
- Translational Science
- Drug Development
Background:
- Preclinical research using animal models informs human clinical trials.
- Many clinical trials fail despite promising preclinical results.
- Replication studies are crucial for understanding preclinical research robustness.
Purpose of the Study:
- To analyze replication in preclinical research trajectories.
- To emphasize the importance of increasing validity in replications.
- To identify key domains for improving research reliability.
Main Methods:
- Discussion of replication strategies within preclinical research.
- Analysis of factors influencing the robustness of experimental results.
- Focus on improving internal, external, and translational validity.
Main Results:
- Replication is essential for validating preclinical findings.
- Prioritizing validity in replication enhances research quality.
- Systematic improvement in validity domains is key.
Conclusions:
- Improving internal, external, and translational validity is critical.
- Enhanced validity leads to more efficient resource allocation.
- Increased validity ultimately improves the success rate of clinical translation.
Related Concept Videos
01:28Preclinical Development: Overview
02:31Replication in Eukaryotes
02:35Replication in Prokaryotes
01:27Reproductive Cloning
Somatic Cell Nuclear Transfer
In SCNT, an egg cell is taken from an animal and its nucleus is removed, creating an enucleated egg. Then a somatic...